Loomis Sayles & CO L P Global Blood Therapeutics, Inc. Transaction History

Loomis Sayles & CO L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $10.2 Million - $15.1 Million	-324,183 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $134,596 - $180,996	-3,542 Reduced 1.08%	324,183 $12.3 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $1.23 Million - $1.59 Million	31,743 Added 10.72%	327,725 $14.8 Million
Q1 2018 May 11, 2018	SELL	$39.6 - $65.9 $2.58 Million - $4.29 Million	-65,112 Reduced 18.03%	295,982 $14.3 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $10.7 Million - $16.5 Million	361,094	361,094 $14.2 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.